BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 31060821)

  • 1. Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.'s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.01.008.
    Bravi CA; Mottrie A
    Eur Urol Focus; 2023 Sep; 9(5):843. PubMed ID: 36898944
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, et al.'s Letter to the Editor re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428-35.
    Tilki D; Chen MH; D'Amico AV
    Eur Urol Oncol; 2024 Feb; 7(1):166. PubMed ID: 37316399
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Roselyne Choinière, Philippe D. Violette, Mélanie Morin, et al. Evaluation of Benefits and Harms of Surgical Treatments for Post-radical Prostatectomy Urinary Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2022;8:1042-52.
    Tutolo M; Briganti A; Salonia A; Montorsi F
    Eur Urol Focus; 2023 Sep; 9(5):849-850. PubMed ID: 37012087
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Alessandro Guercio, Antonio Franco, Elisa Mancini, et al's Letter to the Editor re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. 2024;85:445-456.
    Ramos R; Kaouk J
    Eur Urol; 2024 Jun; 85(6):e171-e172. PubMed ID: 38521615
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Madhur Anand, Bela Jain, and Swati Aggarwal's Letter to the Editor re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-Specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491-502.
    Hartrampf PE; Rowe SP; Pomper MG; Higuchi T; Gorin MA; Werner RA
    Eur Urol; 2024 May; 85(5):e146-e147. PubMed ID: 38087733
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491-502.
    Anand M; Jain B; Aggarwal S
    Eur Urol; 2024 May; 85(5):e145. PubMed ID: 38092614
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013-4.
    Gandaglia G; Bray F; Cooperberg MR; Karnes RJ; Leveridge MJ; Moretti K; Murphy DG; Penson DF; Miller DC
    Eur Urol; 2016 Jun; 69(6):1015. PubMed ID: 26443428
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply from Authors re: Tillmann Loch, Pat Fox Fulgham. Active Surveillance Challenges in Men with Prostate Cancer: Role of Imaging Today and Tomorrow. Eur Urol 2016;69:1034-6: Imaging in Active Surveillance for Prostate Cancer: Where Should We Focus Our Research?
    Henderson DR; de Souza NM; Parker CC; van As NJ
    Eur Urol; 2016 Jun; 69(6):1037. PubMed ID: 26691314
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Tianrui Feng, Miao Ren, and Zhien Zhou's Letter to the Editor re: Peter Fletcher, Marta De Santis, Simona Ippoliti, et al. Vector Prostate Biopsy: A Novel Magnetic Resonance Imaging/Ultrasound Image Fusion Transperineal Biopsy Technique Using Electromagnetic Needle Tracking Under Local Anaesthesia. Eur Urol 2023;83:249-56.
    Fletcher P; Kastner C
    Eur Urol; 2023 Nov; 84(5):e115. PubMed ID: 37202313
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to 'Letter to the Editor regarding "Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al.'.
    Parker CC; Catton CN; Clarke N; Meidahl P; Parmar M; Parulekar W; Sydes M
    Ann Oncol; 2024 May; ():. PubMed ID: 38761889
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the editor: Reply to Ali et al.
    Kim MS; Wilke DR
    Clin Transl Radiat Oncol; 2024 May; 46():100776. PubMed ID: 38654940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author reply Re:Kumar A, Yadav S, Krishnappa RS, Gautam G, Raghavan N, Bakshi G,
    Saini G; Kumar A; Yadav S
    Indian J Urol; 2023; 39(3):251-252. PubMed ID: 37575172
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter re: Letter to the Editor: Reply to Srihari et al.
    Portelli Tremont JN; Kratzke IM
    Am Surg; 2024 Jan; 90(1):159. PubMed ID: 34472990
    [No Abstract]   [Full Text] [Related]  

  • 14. [Debate about Accural Accounting - Reply and Response].
    Stüber S; Christofzik DI; Dorn F; Gäbler S; Raffer C; Rösel F
    Wirtschaftsdienst; 2021; 101(2):138-143. PubMed ID: 33642649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to letter to the editor "Bureaucracy or Streamlining the Rules in "Good Clinical Practice (GCP)" - Has Equipoise Occurred?" by H. K. Kotikonda, V. G. Jonnalagadda and S. R. Venna.
    Perez-Gracia JL; Penel N; Calvo E; Arkenau HT; Amaral T; Grünwald V; Sanmamed MF
    Ann Oncol; 2023 May; 34(5):498-499. PubMed ID: 37121610
    [No Abstract]   [Full Text] [Related]  

  • 16. Félix Pérez-Villa.
    Farrero M; Roig E
    Rev Esp Cardiol (Engl Ed); 2021 Oct; ():. PubMed ID: 34654682
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to H.S. Hochster.
    Hertz DL
    J Clin Oncol; 2023 Apr; 41(11):2120-2121. PubMed ID: 36763926
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Pablo Sierra's Letter to the Editor re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.
    Preisser F; Tilki D
    Eur Urol; 2019 Aug; 76(2):e42. PubMed ID: 31060821
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14.
    Montorsi F; Fossati N; Gandaglia G; Briganti A
    Eur Urol; 2020 Apr; 77(4):e107. PubMed ID: 31980310
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.